Swedish Orphan Biovitrum Stock Today
| BIOVF Stock | USD 25.00 0.00 0.00% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Swedish Orphan is trading at 25.00 as of the 18th of April 2024. This is a No Change since the beginning of the trading day. The stock's lowest day price was 25.0. Swedish Orphan has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Swedish Orphan Biovitrum are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 28th of July 2022 and ending today, the 18th of April 2024. Click here to learn more.
Swedish Orphan Biovitrum AB , an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haematology, immunology, and genetic and metabolic diseases in Europe, North America, and internationally. The company has 295.99 M outstanding shares. More on Swedish Orphan Biovitrum
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Swedish Pink Sheet Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Swedish Orphan's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Swedish Orphan or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Geoffrey McDonough |
| Business Concentration | Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Swedish Orphan Biovitrum [BIOVF] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Mid-Cap' category with a current market capitalization of 6.99 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Swedish Orphan's market, we take the total number of its shares issued and multiply it by Swedish Orphan's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Swedish Orphan Biovitrum classifies itself under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 295.99 M outstanding shares.
Swedish Orphan Biovitrum has accumulated about 280.15 M in cash with 5.47 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.04.
Check Swedish Orphan Probability Of Bankruptcy
Ownership AllocationSwedish Orphan Biovitrum shows a total of 295.99 Million outstanding shares. The majority of Swedish Orphan Biovitrum outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Swedish Orphan to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Swedish Orphan Biovitrum. Please pay attention to any change in the institutional holdings of Swedish Orphan Biovitrum as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Swedish Ownership Details
Swedish Stock Price Odds Analysis
In reference to a normal probability distribution, the odds of Swedish Orphan jumping above the current price in 90 days from now is about 74.68%. The Swedish Orphan Biovitrum probability density function shows the probability of Swedish Orphan pink sheet to fall within a particular range of prices over 90 days. Assuming the 90 days horizon Swedish Orphan Biovitrum has a beta of -0.6972 suggesting as returns on the benchmark increase, returns on holding Swedish Orphan are expected to decrease at a much lower rate. During a bear market, however, Swedish Orphan Biovitrum is likely to outperform the market. Additionally, swedish Orphan Biovitrum has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Swedish Orphan to move above the current price in 90 days from now is about 74.68 (This Swedish Orphan Biovitrum probability density function shows the probability of Swedish Pink Sheet to fall within a particular range of prices over 90 days) .
Swedish Orphan Biovitrum Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Swedish Orphan market risk premium is the additional return an investor will receive from holding Swedish Orphan long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Swedish Orphan. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Swedish Orphan's alpha and beta are two of the key measurements used to evaluate Swedish Orphan's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 0.9225 | |||
| Standard Deviation | 2.79 | |||
| Variance | 7.8 | |||
| Risk Adjusted Performance | (0.01) |
Swedish Stock Against Markets
Picking the right benchmark for Swedish Orphan pink sheet is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Swedish Orphan pink sheet price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Swedish Orphan is critical whether you are bullish or bearish towards Swedish Orphan Biovitrum at a given time. Please also check how Swedish Orphan's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Swedish Orphan without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run FinTech Suite Now
FinTech SuiteUse AI to screen and filter profitable investment opportunities |
| All Next | Launch Module |
Swedish Orphan Corporate Directors
Swedish Orphan corporate directors refer to members of a Swedish Orphan board of directors. The board of directors generally takes responsibility for the Swedish Orphan's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Swedish Orphan's board members must vote for the resolution. The Swedish Orphan board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Lennart Johansson | Director | Profile | |
| BoGunnar Rosenbrand | Director, Employee Representative | Profile | |
| Adine Axen | Independent Director | Profile | |
| David Allsop | Director | Profile |
How to buy Swedish Pink Sheet?
Before investing in Swedish Orphan, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Swedish Orphan. To buy Swedish Orphan stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Swedish Orphan. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Swedish Orphan stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Swedish Orphan Biovitrum stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Swedish Orphan Biovitrum stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Swedish Orphan Biovitrum, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments.
Already Invested in Swedish Orphan Biovitrum?
The danger of trading Swedish Orphan Biovitrum is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Swedish Orphan is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Swedish Orphan. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Swedish Orphan Biovitrum is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Swedish Orphan Biovitrum. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Complementary Tools for Swedish Pink Sheet analysis
When running Swedish Orphan's price analysis, check to measure Swedish Orphan's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Swedish Orphan is operating at the current time. Most of Swedish Orphan's value examination focuses on studying past and present price action to predict the probability of Swedish Orphan's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Swedish Orphan's price. Additionally, you may evaluate how the addition of Swedish Orphan to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |